Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
18/02/2026
According to reports, Thyssenkrupp's stock price rose by 4.1% after it was reported that the company may potentially spin off its materials trading division as early as 2026.
Latest
5 m ago
Moderna CEO: We need guidelines that will not change every year.
6 m ago
Modena: We need to consistently adhere to clear and specific regulatory rules.
7 m ago
Moderna CEO: We do agree to add an additional post-listing requirement for research.
9 m ago
Infineon CEO Jochen Hanebeck said that this German semiconductor manufacturer is well prepared to benefit from the thriving development of the future humanoid robot microchip market. "This could develop into a growth market similar to the high-performance semiconductor market for artificial intelligence data centers today," Hanebeck said. He also added that part of the reason why Infineon currently has the capacity to produce a large number of microchips for humanoid robots is due to its relatively limited business in the autonomous driving sector and its need for new internal technology research and development.
9 m ago
Moderna's pre-market stock price rose by 5.8% at one point.
See all latest